• Return to Headlines

Shares of Abbvie Inc Rise Above Previous 52-Week High

By Nick Russo

Shares of Abbvie Inc (NYSE:ABBV) traded today at $75.85, breaking its 52-week high. Approximately 784,000 shares have changed hands today, as compared to an average 30-day volume of 6.4 million shares.

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Abbvie Inc (NYSE:ABBV) is currently priced 3.4% above its average consensus analyst price target of $73.22. Abbvie Inc shares have support at the 200-day moving average (MA) of $58.94 and additional support at the 50-day MA of $58.23.

Over the past year, Abbvie Inc has traded in a range of $55.06 to $75.85 and is now at $75.78, 38% above that low. The 200-day and 50-day moving averages have moved 0.29% lower and 0.95% higher over the past week, respectively.

SmarTrend is monitoring the recent change of momentum in Abbvie Inc. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Abbvie Inc in search of a potential trend change.

Keywords: 52 week high/lows abbvie inc

Ticker(s): ABBV